Trial intelligence / Profile preview

Curcumin plus piperine in non-proliferative diabetic retinopathy

IRCT20201129049534N5Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of curcumin in diabetic retinopathy (NPDR), sponsored by Isfahan University of Medical Sciences. Started Oct 2021; status: completed.

02

Drugs

curcumin
03

Conditions

diabetic retinopathy (NPDR)

Beyond the preview

Go deeper on IRCT20201129049534N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201129049534N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call